Algal-oil capsules and cooked salmon: nutritionally equivalent sources of docosahexaenoic acid
- PMID: 18589030
- DOI: 10.1016/j.jada.2008.04.020
Algal-oil capsules and cooked salmon: nutritionally equivalent sources of docosahexaenoic acid
Abstract
Food and nutrition professionals question whether supplement-sourced nutrients appear to be equivalent to those derived from natural food sources. We compared the nutritional availability of docosahexaenoic acid (DHA) from algal-oil capsules to that from assayed cooked salmon in 32 healthy men and women, ages 20 to 65 years, in a randomized, open-label, parallel-group study. In this 2-week study comparing 600 mg DHA/day from algal-oil capsules to that from assayed portions of cooked salmon, mean change from baseline in plasma phospholipids and erythrocyte DHA levels was analyzed and DHA levels were compared by Student's t tests. In post-hoc analyses to determine bioequivalence, least-squares mean ratios of percent change from baseline in plasma phospholipid and erythrocyte DHA levels were compared. DHA levels increased by approximately 80% in plasma phospholipids and by approximately 25% in erythrocytes in both groups. Changes in DHA levels in plasma phospholipids and erythrocytes were similar between groups. As measured by delivery of DHA to both plasma and erythrocytes, fish and algal-oil capsules were equivalent. Both regimens were generally well-tolerated. These results indicate that algal-oil DHA capsules and cooked salmon appear to be bioequivalent in providing DHA to plasma and red blood cells and, accordingly, that algal-oil DHA capsules represent a safe and convenient source of non-fish-derived DHA.
Similar articles
-
Bioequivalence of Docosahexaenoic acid from different algal oils in capsules and in a DHA-fortified food.Lipids. 2007 Nov;42(11):1011-24. doi: 10.1007/s11745-007-3098-5. Epub 2007 Aug 23. Lipids. 2007. PMID: 17713804 Clinical Trial.
-
Bioavailability and safety of a high dose of docosahexaenoic acid triacylglycerol of algal origin in cystic fibrosis patients: a randomized, controlled study.Nutrition. 2006 Jan;22(1):36-46. doi: 10.1016/j.nut.2005.05.006. Epub 2005 Oct 12. Nutrition. 2006. PMID: 16226012 Clinical Trial.
-
The effect of supplementation with docosahexaenoic and arachidonic acid derived from single cell oils on plasma and erythrocyte fatty acids of pregnant women in the second trimester.Prostaglandins Leukot Essent Fatty Acids. 2000 Nov;63(5):323-8. doi: 10.1054/plef.2000.0221. Prostaglandins Leukot Essent Fatty Acids. 2000. PMID: 11090260 Clinical Trial.
-
Clinical overview of algal-docosahexaenoic acid: effects on triglyceride levels and other cardiovascular risk factors.Am J Ther. 2009 Mar-Apr;16(2):183-92. doi: 10.1097/MJT.0b013e31817fe2be. Am J Ther. 2009. PMID: 19145206 Review.
-
Canine plasma and erythrocyte response to a docosahexaenoic acid-enriched supplement: characterization and potential benefits.Vet Ther. 2005 Spring;6(1):29-42. Vet Ther. 2005. PMID: 15906268 Review.
Cited by
-
Decreasing the linoleic acid to alpha-linolenic acid diet ratio increases eicosapentaenoic acid in erythrocytes in adults.Lipids. 2010 Aug;45(8):683-92. doi: 10.1007/s11745-010-3430-3. Epub 2010 May 22. Lipids. 2010. PMID: 20496049 Clinical Trial.
-
Docosahexaenoic acid supplementation from mid-pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women.J Nutr. 2011 Feb;141(2):321-6. doi: 10.3945/jn.110.126870. Epub 2010 Dec 22. J Nutr. 2011. PMID: 21178076 Free PMC article. Clinical Trial.
-
Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial.JAMA. 2010 Nov 3;304(17):1903-11. doi: 10.1001/jama.2010.1510. JAMA. 2010. PMID: 21045096 Free PMC article. Clinical Trial.
-
Current evidence for the clinical use of long-chain polyunsaturated n-3 fatty acids to prevent age-related cognitive decline and Alzheimer's disease.J Nutr Health Aging. 2013 Mar;17(3):240-51. doi: 10.1007/s12603-012-0431-3. J Nutr Health Aging. 2013. PMID: 23459977
-
Optimal omegas - barriers and novel methods to narrow omega-3 gaps. A narrative review.Front Nutr. 2024 Feb 2;11:1325099. doi: 10.3389/fnut.2024.1325099. eCollection 2024. Front Nutr. 2024. PMID: 38371504 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials